Bactobio
Signal active
Organization
Contact Information
Overview
Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications.
It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens - before moving on to broader applications.
About
Industries
Biotechnology
Founded
2020
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Bactobio headquartered in Europe, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $150.9M in funding across 12 round(s). With a team of 11-50 employees, Bactobio is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Bactobio, raised $7.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$12.6M
Details
2
Bactobio has raised a total of $12.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 1.5M | ||
| 2021 | Seed | 3.8M |
Investors
Bactobio is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Bridford Group | - | FUNDING ROUND - Bridford Group | 7.3M |
| Peder Nielsen | - | FUNDING ROUND - Peder Nielsen | 7.3M |
| Bactobio | - | FUNDING ROUND - Bactobio | 7.3M |
| Hugh Grant | - | FUNDING ROUND - Hugh Grant | 7.3M |
Recent Activity
There is no recent news or activity for this profile.